Drug Type Small molecule drug |
Synonyms BEP-800, NVP BEP800, NVP-BEP800 + [2] |
Target |
Mechanism HSP90 inhibitors(Heat shock 90kDa proteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23Cl2N5O2S |
InChIKeyWJUNQSYQHHIVFX-UHFFFAOYSA-N |
CAS Registry847559-80-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Preclinical | FR | - | |
Acute Lymphoblastic Leukemia | Preclinical | FR | - | |
Neoplasms | Preclinical | - | - | |
Neoplasms | Preclinical | - | - |